cannabineer
Ursus marijanus
musta been God’s verified Twitter account.
The Junk Drawer
- Thread starter Jimdamick
- Start date
printer
Well-Known Member
A slow changing wind.
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD.
The Medical Marijuana and Cannabidiol Research Expansion Act was passed on Wednesday through unanimous consent by a voice vote and will now head to President Biden’s desk to be signed.
The bill, passed by the House in July, establishes a new registration process for researching marijuana and its derivatives. Under the provisions of this legislation, the Drug Enforcement Administration (DEA) will be directed to register entities who conduct marijuana research and those who supply the marijuana.
The registered entities will be permitted to manufacture, distribute, dispense and possess marijuana or CBD for medical research purposes.
“There is substantial evidence that marijuana-derived medications can and are providing major health benefits. Our bill will make it easier to study how these medications can treat various conditions, resulting in more patients being able to easily access safe medications,” said Sen. Dianne Feinstein (D-Calif.), who introduced the bill along with Sens. Chuck Grassley (R-Iowa) and Brian Schatz (D-Hawaii).
Until this year, the the National Center for the Development of Natural Products at the University of Mississippi was the only approved supplier of marijuana for research purposes in the U.S. The marijuana grown at the Mississippi facility was exclusively grown for research conducted by the National Institute on Drug Abuse.
However, the DEA said in 2021 that it would prioritizing efforts to expand marijuana research. The agency approved six new entities this year to grow marijuana for research including the Scottsdale Research Institute in Arizona and Royal Emerald Pharmaceuticals in California.
“At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able fully study the impacts of cannabis use,” said Rep. Earl Blumenauer (D-Oreg.), co-chair and founder of the Congressional Cannabis Caucus.
At the moment, 37 U.S. states and D.C. allow for the medical use of marijuana. With the recent midterm elections, nearly half of all states also now allow for adult recreational use of the drug.
In October, Biden also asked the secretary of Health and Human Services and the attorney general to review marijuana’s status as a Schedule I drug. This status places marijuana in the same category as heroin and LSD, designating it as a substance with no medical value and a high potential for abuse.
thehill.com
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD.
The Medical Marijuana and Cannabidiol Research Expansion Act was passed on Wednesday through unanimous consent by a voice vote and will now head to President Biden’s desk to be signed.
The bill, passed by the House in July, establishes a new registration process for researching marijuana and its derivatives. Under the provisions of this legislation, the Drug Enforcement Administration (DEA) will be directed to register entities who conduct marijuana research and those who supply the marijuana.
The registered entities will be permitted to manufacture, distribute, dispense and possess marijuana or CBD for medical research purposes.
“There is substantial evidence that marijuana-derived medications can and are providing major health benefits. Our bill will make it easier to study how these medications can treat various conditions, resulting in more patients being able to easily access safe medications,” said Sen. Dianne Feinstein (D-Calif.), who introduced the bill along with Sens. Chuck Grassley (R-Iowa) and Brian Schatz (D-Hawaii).
Until this year, the the National Center for the Development of Natural Products at the University of Mississippi was the only approved supplier of marijuana for research purposes in the U.S. The marijuana grown at the Mississippi facility was exclusively grown for research conducted by the National Institute on Drug Abuse.
However, the DEA said in 2021 that it would prioritizing efforts to expand marijuana research. The agency approved six new entities this year to grow marijuana for research including the Scottsdale Research Institute in Arizona and Royal Emerald Pharmaceuticals in California.
“At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able fully study the impacts of cannabis use,” said Rep. Earl Blumenauer (D-Oreg.), co-chair and founder of the Congressional Cannabis Caucus.
At the moment, 37 U.S. states and D.C. allow for the medical use of marijuana. With the recent midterm elections, nearly half of all states also now allow for adult recreational use of the drug.
In October, Biden also asked the secretary of Health and Human Services and the attorney general to review marijuana’s status as a Schedule I drug. This status places marijuana in the same category as heroin and LSD, designating it as a substance with no medical value and a high potential for abuse.
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD. The Medical Marijuana and Cannabidiol Research Expansion Act was pass…
thehill.com
DIY-HP-LED
Well-Known Member
A good wedge issue for democrats in the houseA slow changing wind.
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD.
The Medical Marijuana and Cannabidiol Research Expansion Act was passed on Wednesday through unanimous consent by a voice vote and will now head to President Biden’s desk to be signed.
The bill, passed by the House in July, establishes a new registration process for researching marijuana and its derivatives. Under the provisions of this legislation, the Drug Enforcement Administration (DEA) will be directed to register entities who conduct marijuana research and those who supply the marijuana.
The registered entities will be permitted to manufacture, distribute, dispense and possess marijuana or CBD for medical research purposes.
“There is substantial evidence that marijuana-derived medications can and are providing major health benefits. Our bill will make it easier to study how these medications can treat various conditions, resulting in more patients being able to easily access safe medications,” said Sen. Dianne Feinstein (D-Calif.), who introduced the bill along with Sens. Chuck Grassley (R-Iowa) and Brian Schatz (D-Hawaii).
Until this year, the the National Center for the Development of Natural Products at the University of Mississippi was the only approved supplier of marijuana for research purposes in the U.S. The marijuana grown at the Mississippi facility was exclusively grown for research conducted by the National Institute on Drug Abuse.
However, the DEA said in 2021 that it would prioritizing efforts to expand marijuana research. The agency approved six new entities this year to grow marijuana for research including the Scottsdale Research Institute in Arizona and Royal Emerald Pharmaceuticals in California.
“At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able fully study the impacts of cannabis use,” said Rep. Earl Blumenauer (D-Oreg.), co-chair and founder of the Congressional Cannabis Caucus.
At the moment, 37 U.S. states and D.C. allow for the medical use of marijuana. With the recent midterm elections, nearly half of all states also now allow for adult recreational use of the drug.
In October, Biden also asked the secretary of Health and Human Services and the attorney general to review marijuana’s status as a Schedule I drug. This status places marijuana in the same category as heroin and LSD, designating it as a substance with no medical value and a high potential for abuse.
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD. The Medical Marijuana and Cannabidiol Research Expansion Act was pass…
DoubleAtotheRON
Well-Known Member
I did. I had thought they could have spent that program on homeless Veterans first, but discovered that they do at SF.Gov, but was developed during the hight of the pandemic, and it was kinda on the struggle bus (like everything else) during that time. But glad to see that they do have a program in place for them... so, carry on.
DoubleAtotheRON
Well-Known Member
Its about time!... As a grower, we of course have to submit lab testing. We can see the percentage of different terpenes/cannabinoids in each sample batch such as Cedrol, Camphene, Neroidol, Pinene, bCaryophylene, etc. Pardon the sloppy chart, but we have tried to isolate certain dominant terpenes to see what affect they have on the body. Surely we have a way to separate these terpenes and do more research in a lab setting.A slow changing wind.
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD.
The Medical Marijuana and Cannabidiol Research Expansion Act was passed on Wednesday through unanimous consent by a voice vote and will now head to President Biden’s desk to be signed.
The bill, passed by the House in July, establishes a new registration process for researching marijuana and its derivatives. Under the provisions of this legislation, the Drug Enforcement Administration (DEA) will be directed to register entities who conduct marijuana research and those who supply the marijuana.
The registered entities will be permitted to manufacture, distribute, dispense and possess marijuana or CBD for medical research purposes.
“There is substantial evidence that marijuana-derived medications can and are providing major health benefits. Our bill will make it easier to study how these medications can treat various conditions, resulting in more patients being able to easily access safe medications,” said Sen. Dianne Feinstein (D-Calif.), who introduced the bill along with Sens. Chuck Grassley (R-Iowa) and Brian Schatz (D-Hawaii).
Until this year, the the National Center for the Development of Natural Products at the University of Mississippi was the only approved supplier of marijuana for research purposes in the U.S. The marijuana grown at the Mississippi facility was exclusively grown for research conducted by the National Institute on Drug Abuse.
However, the DEA said in 2021 that it would prioritizing efforts to expand marijuana research. The agency approved six new entities this year to grow marijuana for research including the Scottsdale Research Institute in Arizona and Royal Emerald Pharmaceuticals in California.
“At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able fully study the impacts of cannabis use,” said Rep. Earl Blumenauer (D-Oreg.), co-chair and founder of the Congressional Cannabis Caucus.
At the moment, 37 U.S. states and D.C. allow for the medical use of marijuana. With the recent midterm elections, nearly half of all states also now allow for adult recreational use of the drug.
In October, Biden also asked the secretary of Health and Human Services and the attorney general to review marijuana’s status as a Schedule I drug. This status places marijuana in the same category as heroin and LSD, designating it as a substance with no medical value and a high potential for abuse.
Senate passes marijuana medication bill
The Senate passed a bill on Wednesday night that will expand research into the potential medical benefits of marijuana and CBD. The Medical Marijuana and Cannabidiol Research Expansion Act was pass…
One thing we know for sure, is that THC is just a catalyst for these terpenes. It doesn't take much THC to set them off, as long as the terpenes are there. You can see that Orange Kush Cake tested at 5.11 terps, which was dominant in Limomene, and Myrcene.... and those terps are good for anxiety. .... and good for me personally. However, IF we could separate each one, maybe we could come up with meds that do not have crazy side affects like the Pharma Drug commercials advertise. It could be a better option for people on ssri's, antidepressants, and Benzo's, or anti inflammatory terpenes that don't destroy your liver.
Last edited:
printer
Well-Known Member
DIY-HP-LED
Well-Known Member
Even MTG?
DIY-HP-LED
Well-Known Member
I was referring to recreational legalization similar to Canada, it would be a wedge for the republicans in the house and senate.
DIY-HP-LED
Well-Known Member
How much you get per pound? Up here you can buy a pound of very good pot (why grow shit) on the native reservations for $200 retail. Government dope where I live @23% THC goes for $125 retail; the most expensive source and local reservations will sell it for $40 to $60 an ounce, again, for very good bud. It is legal to mail pot from one end of the county to another and an ounce vacuum packed and flattened out can be mailed for letter rate. There are hundreds of MOMs some working from several different store fronts online. There is a legal, grey and black market for pot
There are over 7 million google results for online dispensaries in a country of 30 some million, they might be in your future, so have a peek at a few, they are technically illegal, but the Mounties are not interested in pot any more.
printer
Well-Known Member
She is in the House, the Senate voted. Of course the MAGA's will vote against anything but a good portion of Republican states have some sort of marijuana freedoms. Some will vote against it even though the State is for it.
DIY-HP-LED
Well-Known Member
Buy Bulk Weed Online at Cheap Weed | Canada's #1 Dispensary
Looking to buy weed online in Canada? Discover the best online dispensary for bulk weed. Shop now and enjoy quality products & discreet shipping!
cheapweed.io
DoubleAtotheRON
Well-Known Member
It's getting close to your pricing here in Oklahoma. (legal market).. We actually just shut down our op because the pricing got to be ridiculous, and now we just grow for our own consumption, or make oils for our friends and family. We have found a pheno that I've had for about 4 years that in oral form, has lowered my dads A1C from 10.4, down to 6.2 within 5 months. We tested this theory by having him stop for about 6 months. ... it was back up to 10.4. In April I put him back on them till his next lab this past Aug. It was back down to 6.4 (normal range).. I'd have to go back in our books to see what the dominate terpene was in that one, but it was just by chance we got it right.
DIY-HP-LED
Well-Known Member
Roger A. Shrubber
Well-Known Member
I don't think it was ever meant to bring peace...It was a tool the weak but educated clergy could use to control the masses, helping to guarantee their safety from the nobility, who were jealous of their authority and power.
There's never been anything devine about it.
DIY-HP-LED
Well-Known Member
If this is hard for you to relate to, you are probably Donald Trump or like him, or voted for him.
DIY-HP-LED
Well-Known Member
DIY-HP-LED
Well-Known Member
